In this issue:
Promising early efficacy for an anti- B7H3 ADC for advanced refractory tumours
Immunotherapy may negate surgery for early-stage dMMR cancers
Oncological and functional outcomes improved with robotic surgery for rectal cancer
Apalutamide bests enzalutamide for mCSPC in real-world setting
Toxicity with IMRT vs SBRT for higherrisk prostate cancer
PSMAfore: Patient-reported outcomes with 177Lu-PSMA-617
Cabozantinib + atezolizumab vs ARPI switch for mCRPC
Liquid biopsy may inform targeted therapy later-line targeted therapy in mCRC
Zipalertinib efficacious in EGFR ex20ins mutated NSCLC
Intratympanic sodium thiosulfate injections may mitigate chemotherapy ototoxicity
Please login below to download this issue (PDF)